• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Allergy Asthma Rep . Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group

tetano

Editor, Senior Moderator
Curr Allergy Asthma Rep


. 2021 Feb 25;21(2):13.
doi: 10.1007/s11882-020-00986-6.
Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group


D?sir?e Larenas-Linnemann[SUP] 1 2 [/SUP], Jorge Luna-Pech[SUP] 3 [/SUP], Elsy M Navarrete-Rodr?guez[SUP] 4 [/SUP], Noel Rodr?guez-P?rez[SUP] 5 [/SUP], Alfredo Arias-Cruz[SUP] 6 [/SUP], Mar?a Virginia Bland?n-Vijil[SUP] 7 [/SUP], Blanca E Del Rio-Navarro[SUP] 4 [/SUP], Alan Estrada-Cardona[SUP] 8 [/SUP], Ernesto Onuma-Takane[SUP] 7 [/SUP], Cesar Fireth Pozo-Beltr?n[SUP] 9 [/SUP], Adriana Mar?a Valencia-Herrera[SUP] 10 [/SUP], Francisco Ignacio Ortiz-Aldana[SUP] 11 [/SUP], Mirna Er?ndira Toledo-Bahena[SUP] 10 [/SUP]



Affiliations

Abstract

Purpose of review: At the juncture of the COVID-19 pandemic, the world is currently in an early phase of collecting clinical data and reports of its skin manifestations, and its pathophysiology is still highly conjectural. We reviewed cutaneous manifestations associated with COVID-19 in the pediatric age group.
Recent findings: Children infected by SARS-CoV-2 usually develop milder respiratory symptoms, but cutaneous manifestations seem a little more prevalent than in adults. These skin features of infection by the coronavirus can be similar to those produced by other common viruses, but there are also reports of cases with more heterogeneous clinical pictures, which have made their classification difficult. To date, the more frequently reported skin variants featured in pediatric cases are purpuric (pseudo-chilblain, necrotic-acral ischemia, hemorrhagic macules, and/or cutaneous necrosis), morbilliform/maculopapular, erythema multiforme, urticarial, vesicular, Kawasaki-like, and miscellaneous (highly variable in both frequency and severity). Their pathophysiological mechanism is still elusive and is likely to be the result of the complex involvement of one or more mechanisms, like direct virus-induced skin damage, vasculitis-like reactions, and/or indirect injury as a consequence of a systemic inflammatory reaction. In this review, we presented and discussed clinical cases as examples of different cutaneous responses reported in some children with SARS-CoV-2 infection, differential diagnosis considerations, and a preliminary conceptual approach to some of their probable associated pathologic mechanisms.

Keywords: COVID-19, pediatric; Kawasaki-like; Pseudo-chilblain; Purpuric lesion; SARS-COV-2.
 
Back
Top Bottom